Corton Capital Inc. Crispr Therapeutics Ag Transaction History

Corton Capital Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $56,544 - $83,059	-932 Reduced 13.11%	6,179 $421,000
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $65,731 - $122,850	1,702 Added 31.47%	7,111 $445,000
Q3 2023 Nov 14, 2023	BUY	$45.39 - $59.0 $14,207 - $18,467	313 Added 6.14%	5,409 $245,000
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $9,302 - $14,502	214 Added 4.38%	5,096 $286,000
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $25,379 - $34,738	-619 Reduced 11.25%	4,882 $220,000
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $215,584 - $361,250	5,501 New	5,501 $223,000
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $155,022 - $264,754	-3,586 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $190,739 - $284,154	3,586 New	3,586 $225,000

490

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.23B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.